InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
9
T+90 hit rate
11%
T+90 mean return
-26.2%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by ROBERTSON MICHELLE, Chief Financial Officer. Director active across 2 companies, notably Editas Medicine, Inc.. Aggregated, 19 reports have been recorded. Split: 0 buy · 9 sells. Total volume traded: €173k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
8,333 shares0Common StockSEC:0001104659-24-073608:0
949 shares@ US$9.8722.0% of flowCommon StockSEC:0001415889-23-007990:0
31,500 shares0Common StockSEC:0001415889-23-004315:0
4,287 shares@ US$9.66539.0% of flowCommon StockSEC:0001415889-23-002603:0
1,752 shares@ US$8.16013.1% of flowCommon StockSEC:0001415889-23-000875:0
193 shares@ US$10.230.4% of flowCommon StockSEC:0001415889-22-012132:0
192 shares@ US$15.010.7% of flowCommon StockSEC:0001415889-22-009449:0
1,527 shares@ US$11.53690.0082% mcap4.5% of flowCommon StockSEC:0001415889-22-006161:0
767 shares@ US$17.32770.0060% mcap3.3% of flowCommon StockSEC:0001415889-22-002655:0
53,499 shares0Common StockSEC:0001415889-22-001223:0
53,499 shares0Common StockSEC:0001415889-22-001223
1,744 shares@ US$25.700.020% mcap10.8% of flowCommon StockSEC:0001179110-22-000470:0
1,744 shares@ US$25.709.2% of flowCommon StockSEC:0001179110-22-000470
4,471 shares0Common StockSEC:0001179110-21-011224
4,471 shares0Common StockSEC:0001179110-21-011224:0
2,500 shares@ US$30.650.033% mcap17.8% of flowCommon StockSEC:0001179110-21-008086:0
2,500 shares@ US$30.6515.1% of flowCommon StockSEC:0001179110-21-008086
2,500 shares@ US$30.6514.9% of flowCommon StockSEC:0001179110-21-007175
2,500 shares@ US$30.650.032% mcap17.5% of flowCommon StockSEC:0001179110-21-007175:0
19 of 19 declarations
About ROBERTSON MICHELLE
ROBERTSON MICHELLE is the Chief Financial Officer at Editas Medicine, Inc. She is responsible for the financial management of the company, including financial planning and regulatory compliance, contributing to the financial health of the organization.
